Osteonecrosis of jaw (ONJ) in renal cell cancer patients: an emerging problem

Por Fusco, V., Zai, S., Grosso, F., De Martino, I., Randi, L.
Publicado no Ann Stomatol (Roma) (2014)

Outbreak of GES-1 β-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae in a University Hospital in Lisbon, Portugal

Por Duarte, A., Boavida, F., Grosso, F., Correia, M., Lito, L. M., Cristino, J. Melo, Salgado, M. J.
Publicado em 2003

Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies

Por Mandalà, M, Grosso, F, Vitalini, C, Corradino, I, Sanfilippo, R, Colombini, S, Clerici, M, Labianca, R, De Pascale, A, Marsoni, S
Publicado em 2012

Proteasomes are a target of the anti-tumour drug vinblastine.

Por Piccinini, M, Tazartes, O, Mezzatesta, C, Ricotti, E, Bedino, S, Grosso, F, Dianzani, U, Tovo, P A, Mostert, M, Musso, A, Rinaudo, M T
Publicado em 2001

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

Por Cesne, A L, Judson, I, Maki, R, Grosso, F, Schuetze, S, Mehren, M V, Chawla, S P, Demetri, G D, Nieto, A, Tanovic, A, Blay, J-Y
Publicado em 2013

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

Por Ceresoli, G L, Grosso, F, Zucali, P A, Mencoboni, M, Pasello, G, Ripa, C, Degiovanni, D, Simonelli, M, Bruzzone, A, Dipietrantonj, C, Piccolini, E, Beretta, G D, Favaretto, A G, Giordano, L, Santoro, A, Botta, M
Publicado em 2014